Measurement of response to treatment in colorectal liver metastases.

Assessment of tumour response to chemotherapy is important when assessing efficacy of treatment and comparing differing therapeutic regimens. Percentage hepatic replacement (PHR) is commonly used to assess response to treatment of colorectal hepatic metastases. PHR is dependent not only on tumour vo...

Descripción completa

Detalles Bibliográficos
Autores principales: Dworkin, M. J., Burke, D., Earlam, S., Fordy, C., Allen-Mersh, T. G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033728/
https://www.ncbi.nlm.nih.gov/pubmed/7710957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033728/
https://www.ncbi.nlm.nih.gov/pubmed/7710957

Ejemplares similares